Search

ADMA Biologics Inc

Открыт

СекторЗдравоохранение

9.59 0.84

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

9.33

Макс.

9.55

Ключевые показатели

By Trading Economics

Доход

-7.5M

38M

Продажи

9.9M

124M

P/E

Средняя по отрасли

13.329

56.659

Прибыль на акцию

0.16

Рентабельность продаж

30.405

Сотрудники

640

EBITDA

-3.8M

57M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+78.76% upside

Дивиденды

By Acuity

Следующий отчет о доходах

4 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

64M

2.1B

Предыдущая цена открытия

8.75

Предыдущая цена закрытия

9.59

Новостные настроения

By Acuity

37%

63%

97 / 340 Рейтинг в Healthcare

ADMA Biologics Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

28 авг. 2026 г., 20:07 UTC

ADMA Biologics Inc shares are lower today, continuing a three-day decline. The stock remains significantly below its 20-day moving average amid rising Treasury yields.

27 авг. 2026 г., 19:11 UTC

ADMA Biologics Inc. shares are lower today amid pressure on biotechnology stocks, despite a brief uptick earlier in the session. No specific news was identified.

26 авг. 2026 г., 20:08 UTC

ADMA Biologics Inc. shares are lower amid biotechnology sector weakness, with no specific news identified to explain the decline.

25 авг. 2026 г., 19:26 UTC

ADMA Biologics shares are higher today, supported by declining U.S. Treasury yields that typically enhance equity valuations. No specific company news was identified.

24 авг. 2026 г., 20:06 UTC

ADMA Biologics Inc shares are lower during Monday's session, reversing earlier gains amid broader market influences, including rising oil prices and geopolitical tensions.

21 авг. 2026 г., 23:01 UTC

ADMA Biologics Inc shares declined in after-market trading, continuing a trend of lower finishes over the past three sessions amid broader market volatility.

20 авг. 2026 г., 20:06 UTC

ADMA Biologics Inc shares are lower in Thursday's session, with no specific news identified. Broader market declines may be influencing sentiment amid rising Treasury yields.

19 авг. 2026 г., 20:01 UTC

ADMA Biologics Inc shares are higher Wednesday, continuing a strong upward trend since Tuesday's close, despite no specific news driving the move.

17 авг. 2026 г., 19:36 UTC

Correlated Moves
Social Media
News

ADMA Biologics is trading lower amid an investigation into potential fiduciary breaches by its Board of Directors. Broader market sentiment may also be impacting shares.

13 авг. 2026 г., 20:02 UTC

Social Media

ADMA Biologics shares are lower amid concerns over financial practices and potential SEC scrutiny, despite claims of an internal review clearing the company.

12 авг. 2026 г., 19:46 UTC

ADMA Biologics shares are trading lower today, despite broader market gains following a positive inflation report. The stock remains near its one-month high.

11 авг. 2026 г., 22:56 UTC

ADMA Biologics Inc shares are lower in after-market hours following an earlier decline. The price remains above its 20-day moving average.

7 авг. 2026 г., 19:46 UTC

Correlated Moves
News

ADMA Biologics shares are lower following a securities fraud class action lawsuit alleging false statements and undisclosed transactions, amid broader negative market sentiment.

6 авг. 2026 г., 20:02 UTC

News

ADMA Biologics reported second-quarter net income of $37.82 million and revenue of $124.40 million, driving shares higher during Thursday's session.

5 авг. 2026 г., 23:02 UTC

News

ADMA Biologics reported second-quarter revenue of $124.4 million, missing expectations. Shares are lower in after-market trading following the earnings release.

4 авг. 2026 г., 19:46 UTC

News

ADMA Biologics Inc. is trading higher, buoyed by strong momentum and a decline in crude oil prices that eases inflation concerns and supports consumer spending.

3 авг. 2026 г., 19:16 UTC

ADMA Biologics Inc shares are higher today, continuing an upward trend since Friday amid broader market optimism following recent geopolitical developments.

31 июл. 2026 г., 20:06 UTC

News

ADMA Biologics is declining amid a class action lawsuit alleging fraudulent activities, continuing a trend of four consecutive lower sessions.

30 июл. 2026 г., 19:39 UTC

Correlated Moves

ADMA Biologics shares are lower following a decline in first-quarter performance, reflecting broader market sentiment amid ongoing investor concerns.

29 июл. 2026 г., 18:17 UTC

News
Correlated Moves

ADMA Biologics will report second-quarter 2026 results on August 5, contributing to today's higher share price amid steady trading.

28 июл. 2026 г., 20:06 UTC

News

ADMA Biologics Inc. is rising amid broader biotechnology sector strength, despite ongoing legal challenges. The stock has shown steady gains since Monday's close.

27 июл. 2026 г., 19:41 UTC

ADMA Biologics Inc shares are higher today, continuing a strong performance since Friday. No specific news was identified to explain the gains.

24 июл. 2026 г., 19:26 UTC

News

ADMA Biologics shares are lower amid a securities fraud lawsuit alleging inflated revenue growth and related party transactions, impacting investor sentiment.

22 июл. 2026 г., 18:36 UTC

News

ADMA Biologics shares are lower as a class action lawsuit targets investors, alleging false statements about business practices and internal controls.

21 июл. 2026 г., 19:36 UTC

News

ADMA Biologics Inc faces a class action lawsuit alleging securities fraud, contributing to its decline since Monday's close. Shares briefly rebounded earlier in the session.

20 июл. 2026 г., 19:46 UTC

ADMA Biologics Inc shares are higher during Monday's session, despite fluctuations and no specific news to explain the price action since Friday's close.

Сравнение c конкурентами

Изменение цены

ADMA Biologics Inc Прогноз

Целевая цена

By TipRanks

78.76% рост

Прогноз на 12 месяцев

Средняя 17 USD  78.76%

Максимум 21 USD

Минимум 12 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для ADMA Biologics Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

4 ratings

3

Покупка

1

Удержание

0

Продажа

Настроения

By Acuity

97 / 340Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании ADMA Biologics Inc

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
help-icon Live chat